Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
Notice of Meeting
Location: Virtual Meeting
Virtual Attendance: https://meetnow.global/MRGCYTN
Date: Wednesday, 31 January 2024
Time: Commencing at 2:00PM AEST (Brisbane Time)
Verbrec Limited (ASX : VBC)
Level 14, 200 Mary Street
Brisbane QLD 4000
ACN: 127 897 689
verbrec.com
Key Dates
The key dates for the meeting are set out below:
Key Dates
EVENT
DATE
Last day for receipt of proxies #
Monday, 29 January 2024
2:00PM Australian Eastern Standard Time (Brisbane Time)
Snapshot time for eligibility to vote
Monday, 29 January 2024
6:00PM Australian Eastern Standard Time (Brisbane Time)
Meeting
Wednesday, 31 January 2024
2:00PM Australian Eastern Standard Time (Brisbane Time)
# Proxy forms received after 1:00PM AEST (Brisbane Time) on Monday, 29 January 2024 will be disregarded.
Questions
Shareholders are invited to contact the Company Secretary at Investors@verbrec.com if
they have any questions regarding the meeting.
1
Notice of Meeting
Notice is given that the Meeting of Verbrec Limited (ACN: 127 897 689) (ASX : VBC) will be
held on Wednesday, 31 January 2024 commencing at 2:00PM Australian Eastern Standard
Time (Brisbane Time). Shareholders may attend the meeting by following the virtual
attendance link below:
Virtual Attendance: https://meetnow.global/MRGCYTN
The Meeting will be held virtually only.
The Explanatory Statement, which accompanies and forms part of this Notice, contains
information to assist Shareholders including access and registration, and to decide how to
vote on the matters to be considered at the Meeting.
Terms used in this Notice are defined in the Glossary in the Explanatory Statement.
Business
Resolution 1: Issue of Placement Shares to Directors of the Company
To consider and, if thought fit, to pass, the following ordinary resolution:
‘That for the purposes of Listing Rule 10.11, to approve the issue of 1,500,000 Shares to non-executive
Directors of the Company, including Mr. Phillip Campbell, Mr. Matthew Morgan and Ms. Sarah Zeljko, as
detailed in the Explanatory Statement.’
Resolution 2: Issue of Broker Options
To consider and, if thought fit, to pass, the following ordinary resolution:
‘That, for the purposes of Listing Rule 7.1 and for all other purposes, to approve the issue of 6,860,000 Options
to Veritas (Broker Options) as part of the consideration for the services provided as lead manager for the
capital raising activities (including placement of Shares and shortfall of pro-rata entitlement offer)
undertaken in November and December 2023.’
Resolution 3: Ratification of previous issue and allotment of Placement Shares
To consider and, if thought fit, to pass, the following ordinary resolution:
‘That, for the purposes of Listing Rule 7.4, and for all other purposes, to ratify and approve the previous issue
and allotment of 31,823,491 Shares at an issue price of $0.06 per Share on 27 November 2023, as detailed in
the Explanatory Statement.’
By Order of the Board
Joel Voss
JVoss
Company Secretary
Verbrec Limited
29 December 2023
2
Proxy Appointment, Voting and Meeting
Instructions
Meeting details and how to register, vote and ask questions
The Meeting of shareholders of the Company will be held virtually at 2:00pm Australian
Eastern Standard Time (Brisbane time) on Wednesday, 31 January 2024.
You may register to attend the webcast by following the link below:
Virtual Attendance: https://meetnow.global/MRGCYTN
You will be able to vote live during the Meeting by visiting www.investorvote.com.au on a
smartphone, tablet or computer (using the latest version of Chrome, Safari, Microsoft Edge
or Firefox) as per the instructions on the attached Proxy Form.
Online voting registration will commence 30 minutes prior to the start of the General
Meeting and close 5 minutes after the last item of business. For full details on how to log on
and vote online, please refer to the user guide, available online at:
www.computershare.com.au/onlinevotingguide.
You can also lodge your proxy online, by post or by facsimile in accordance with the
instructions contained in the proxy form accompanying this notice.
The Board strongly encourages lodgement of proxy votes and submission of questions
prior to the Meeting so the meeting can be held in an efficient manner.
Lodgement of Proxy Form
The Proxy Form (and any power of attorney or other authority, if any, under which it is
signed) or a copy or facsimile which appears on its face to be an authentic copy of the
Proxy Form (and the power of attorney or other authority) must be lodged no later than
2:00pm Australian Eastern Standard Time (Brisbane time) on Monday, 29 January 2024.
Any Proxy Form received after that time will not be valid for the Meeting. The Proxy Form
may be lodged in one of the following ways:
Online:
Follow the directions on the Proxy Form
By hand:
Level 14, 200 Mary Street, Brisbane QLD 4000
By mail:
Computershare Investor Services Pty Limited, GPO Box 242, Melbourne
VIC 3001 Australia
By fax:
1800 783 447 (within Australia) or +61 3 9473 2555 (outside Australia)
Appointment of a Proxy
A member of the Company entitled to attend and vote at the Meeting is entitled to
appoint a proxy. The proxy may, but need not be, a member of the Company.
If you wish to appoint the Chairperson of the Meeting as your proxy, mark the box. If the
person you wish to appoint as your proxy is someone other than the Chairperson of the
Meeting, please write the name of that person. If you leave this section blank, or your
named proxy does not attend the meeting, the Chairperson of the Meeting will be your
proxy. A proxy need not be a Shareholder of the Company.
3
You are entitled to appoint up to two persons as proxies to attend the Meeting and vote
on a poll. If you wish to appoint a second proxy, an additional Proxy Form may be
obtained by emailing the Company Secretary at Investors@verbrec.com or you may
photocopy the Proxy Form.
To appoint a second proxy, you must on each Proxy Form state (in the appropriate box)
the percentage of your voting rights that are the subject of the relevant proxy. If both
Proxy Forms do not specify that percentage, each proxy may exercise half your votes.
Fractions of votes will be disregarded.
The Chairperson of the Meeting acting as proxy
If a member directs the Chairperson how to vote on an item of business, the Chairperson
must vote in accordance with the direction.
For proxies without voting instructions that are exercisable by the Chairperson, the
Chairperson intends to vote all available proxies in favour of each Resolution.
If you appoint the Chairperson of the meeting as your proxy, or the Chairperson is
appointed as your proxy by default, then unless you mark one of the voting instruction
boxes for the relevant Resolution, you will be taken to have expressly authorised the
Chairperson to vote in favour of that Resolution.
Corporate Shareholders
Corporate Shareholders should comply with the execution requirements set out on the
Proxy Form or otherwise with the provisions of section 127 of the Corporations Act. Section
127 of the Corporations Act provides that a company may execute a document without
using its common seal if the document is signed by:
-
two directors of the company;
-
a director and a company secretary of the company; or
-
for a proprietary company that has a sole director who is also the sole company
secretary – that director.
Votes on Resolution
You may direct your proxy how to vote by placing a mark in one of the boxes opposite
the Resolutions. All your shareholding will be voted in accordance with such a direction
unless you indicate only a portion of voting rights are to be voted on the Resolutions by
inserting the percentage or number of Shares you wish to vote in the appropriate box or
boxes. If you do not mark any of the boxes on the Resolutions, and your proxy is not the
Chairperson, your proxy may vote as he or she chooses. If you mark more than one box
on a Resolution your vote on the Resolutions will be invalid.
Corporate Representatives
A corporation may elect to appoint an individual to act as its representative in
accordance with section 250D of the Corporations Act, in which case the Company will
require a certificate of appointment of the corporate representative executed in
accordance with the Corporations Act. The certificate of appointment must be lodged
with the Company or the Company's share registry, Computershare Investor Services,
before the Meeting or at the registration desk on the day of the Meeting. Certificates for
the appointment of corporate representatives are available at www.computershare.com
4
or on request by contacting Computershare Investor Services on telephone number 1300
552 270 (within Australia) or +61 3 9415 4000 (outside Australia).
Voting Entitlement (Snapshot Time)
The Company's Directors have determined that all Shares of the Company that are
quoted on ASX at 6:00pm Australian Eastern Standard Time (Brisbane time) on Monday, 29
January 2024 will, for the purposes of determining voting entitlements at the Meeting, be
taken to be held by the persons registered as holding the Shares at that time. Transactions
registered after that time will be disregarded in determining entitlements to attend and
vote at the Meeting.
Questions from Shareholders
At the Meeting the Chairperson will allow a reasonable opportunity for Shareholders to ask
questions or make comments.
To assist the Board in responding to questions please submit any questions you may have
in writing no later than 3:00pm Australian Eastern Standard Time (Brisbane time) on
Tuesday, 23 January 2024:
By Email:
Investors@verbrec.com
By hand:
Level 14, 200 Mary Street, Brisbane QLD 4000
By mail:
PO Box 3291, Brisbane GPO QLD 4000
By fax:
+61 7 3058 7111
5
Explanatory Statement
This Explanatory Statement has been prepared for the information of Shareholders in
relation to the business to be conducted at the Meeting.
The purpose of this Explanatory Statement is to provide Shareholders with all information
known to the Company that is material to a decision on how to vote on the Resolutions in
the accompanying Notice.
This Explanatory Statement should be read in conjunction with the Notice. Capitalised
terms in this Explanatory Statement are defined in the Glossary.
Background
On 20 November 2023, the Company announced that it had successfully placed
33,150,000 ordinary fully paid Shares (Placement Shares) under Listing Rule 7.1 by
placement to institutional, sophisticated and strategic investors (Placement).
At the same time, the Company announced the launch of a non-renounceable
entitlement offer to existing shareholders in Australia and New Zealand of 1 new Share for
every 6.5 Shares held on the record date, also at a price of $0.06 (Entitlement Offer), which
if taken up in full by all participants had the potential to raise up to 34,051,571 fully paid
shares. To the extent a shortfall was available after the closing date of the Entitlement
Offer, this would then be placed consistent with Exception 3 of Listing Rule 7.2 (Shortfall
Placement).
The entitlement offer closed on 7 December 2023, and on 14 December 2023 the
Company issued 19,943,579 shares in connection with the Entitlement Offer.
On 15 December 2023, the Company issued 14,107,992 shares as part of the Shortfall
Placement.
6
Resolution 1: Issue of Placement Shares to Directors of the Company
Several non-executive Directors of the Company applied to participate in the Placement,
and to receive Placement Shares, subject to a future approval of the shareholders
pursuant to Listing Rule 10.11.
Accordingly, this Resolution 1 seeks shareholder approval to issue Shares to the Directors
named in the below table pursuant to ASX Listing Rule 10.11.
Listing Rule 10.11 provides that, unless one of the exceptions in Listing Rule 10.12 applies
(which it does not in respect of the Placement), an entity must not issue or agree to issue
equity securities to any of the following persons:
-
a related party;
-
a person who is, or was at any time in the 6 months before the issue or agreement,
a substantial (30% or more) holder in the entity;
-
a person who is, or was at any time in the 6 months before the issue or agreement,
a substantial (10% or more) holder in the entity and who has nominated a director
to the board of the entity pursuant to a relevant agreement which gives them a
right or expectation to do so;
-
an associate of a person referred to in the paragraphs above; or
-
a person whose relationship with the entity or a person referred to in Listing Rules
10.11.1 to 10.11.4 is such that, in ASX’s opinion, the issue or agreement should be
approved by its shareholders,
unless it obtains the approval of its shareholders.
Thus, Shareholder approval is required under Listing Rule 10.11 for the Company to issue
equity securities to a related party (including a Director of the Company). If Resolution 1 is
approved by shareholders, the issue of the Placement Shares to the Directors will be
excluded from the calculation of the Company’s Placement Capacity under Listing Rule
7.1 and, therefore, shareholder approval under Listing Rule 7.1 will not be required for the
purposes of the issue of the Placement Shares to the Directors.
Listing Rule 10.13 sets out the requirements for inclusion in this Notice for the approval of
the issue of securities under Listing Rule 10.11.
This information is provided below:
Details of Issue
Listing Rule 10.13 Requirement
Detail
The name of the person and the number
of securities proposed to be issued to the
person
Name
Number of
securities
Mr Phillip Campbell
833,333
Mr Matthew Morgan
416,667
Ms Sarah Zeljko
250,000
Class of Securities
Fully paid ordinary shares of the Company
(ASX : VBC)
Terms of Issue
7
The Shares rank equally with all existing Shares on issue at the
Issue Date
The purpose of the issue, including the
intended use of any funds raised by the
issue.
General capital raising.
The Company will use any funds received on the exercise of
the Broker Options in accordance with the purposes for which
funds were raised under the Placement, being to:
Which categories in rules 10.11.1 – 10.11.5
the person falls within and why
1.
invest in the growth of core areas of the Company’s
business;
2.
provide working capital for general operational
efficiencies, covering the costs of the divestment of parts
of the Company’s training business and pursuing
recovering of fees related to the final poor performing
legacy project; and
3.
reduce the Company’s net debt position and minimise,
as far as reasonably practicable and prudent, the
Company’s debt draw.
10.11.1, each being a related party as Director of the
Company at the date of the Placement.
* Ms Sarah Zeljko was a Director at the time of the Placement,
but subsequently has retired but remains a related party having
been a Director in the past 6 months.
Details (including the amount) of the
Director’s current total remuneration
package
The following information is provided as part of good corporate
governance, and consistent with Listing Rule 10.13.8. The issue is
not intended to remunerate or incentivise the directors as the
purchase price paid by the directors is the same purchase price
offered in the Entitlement Offer.
Name
Annual Director
Fees
Mr Phillip Campbell
$120,000
Mr Matthew Morgan
$75,000
Ms Sarah Zeljko
$0
($75,000 prior to
retirement)
The date or dates on or by which the
entity will issue the securities, which must
not be more than 1 month after the date
of the meeting
On or before 29 February 2024.
The price or other consideration the
entity will receive for the issue
Name
Total issue price
Mr Phillip Campbell
$49,999.98
Mr Matthew Morgan
$25,000.02
Ms Sarah Zeljko
$15,000.00
Are the securities issued under an
agreement?
No.
Voting exclusion statement
A voting exclusion statement is included
for this resolution below.
For the purposes of Listing Rule 14.1A:
1. If Resolution 1 is passed, the Placement Shares will be issued to the Director’s within
no more than one month from the date of the Meeting consistent with Listing Rule
10.13 and will be excluded in calculating the Company’s Placement Capacity
under Listing Rule 7.1.
8
2. If Resolution 1 is not passed, the Company will refund the amount paid by Directors
for the Shares, and may, at Board discretion, utilise headroom in the Director’s
existing remuneration pool to fund the difference, allowing Director’s to purchase
shares on-market for the same price as the Placement Shares.
Voting exclusion statement
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour
of the resolution by or on behalf of:
-
the person(s) who are to receive the securities in question and any other person
who will obtain a material benefit as a result of the issue of securities (except a
benefit solely by reason of being a holder of ordinary securities in the entity),
including Mr Phillip Campbell, Mr Matthew Morgan & Ms Sarah Zeljko.
-
an associate of that person or persons
However, this does not apply to a vote cast in favour of a resolution by:
-
a person as proxy or attorney for a person who is entitled to vote on the resolution,
in accordance with the directions given to the proxy or attorney to vote on the
resolution in that way; or
-
the chair of the meeting as proxy or attorney for a person who is entitled to vote on
the resolution, in accordance with a direction given to the chair to vote on the
resolution as the chair decides; or
-
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity
on behalf of a beneficiary provided the following conditions are met:
o
the beneficiary provides written confirmation to the holder that the
beneficiary is not excluded from voting, and is not an associate of a person
excluded from voting, on the resolution; and
o
the holder votes on the resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Director’s recommendation
The Directors consistent with good corporate governance refrain from providing a
recommendation in relation to this resolution.
Resolution 2: Issue of Broker Options
Veritas Securities Limited (Veritas) was the lead broker for the Placement and the Shortfall
Placement.
As notified in the announcement on 20 November 2023, the Company has agreed to issue
4,000,000 options to acquire Shares to Veritas, as well as to issue to Veritas one Broker
Option for every $1.00 in gross proceeds from the Placement and the Shortfall Placement
(but not the Entitlement Offer) (Broker Options). This agreement was subject to the
Company applying for and receiving shareholder approval consistent with Listing Rule 7.1.
The Broker Options have an exercise price of $0.09 and expire two years from the date of
issue.
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount
of equity securities that a listed company can issue without the approval of its
shareholders over any 12-month period to 15% of the fully paid ordinary shares it had on
issue at the start of that period (Placement Capacity).
9
The Placement utilised the Company’s Placement Capacity, and accordingly, the
Company seeks approval under this Resolution 2 to issue the Broker Options consistent with
Listing Rule 7.1.
If shareholders approve the issue of the Broker Options under this Resolution 2, the issue of
the Broker Options will not contribute to the calculation of the Company’s Placement
Capacity.
Listing Rule 7.3 provides the details that are required to be provided under Listing Rule 7.1
in the notice of meeting seeking shareholder approval:
Details of Broker Options
Listing Rule 7.3 Requirement
Detail
The names of the persons to whom the entity will
issue the securities or the basis upon which those
persons were or will be identified or selected.
Veritas Securities Limited
The class of securities the entity will issue
Broker Options (to acquire Shares)
The number of securities the entity will issue
6,860,000
If the securities are not fully paid, a summary of the
material terms of the securities
Exercise Price = $0.09
Expiry: Two years after date of issue
The material terms of the Broker Options is attached
as an Appendix to this Notice.
The date or dates on or by which the entity will issue
the securities.
No later than 3 months after the date of the
meeting.
The price or other consideration the entity will
receive for the securities
Price = Nil
The purpose of the issue, including the intended use
of any funds raised by the issue
As above
(provided as consideration for Veritas acting as lead
broker for the Placement and Shortfall Placement).
The Company will use any funds received on the
exercise of the Broker Options in accordance with
the purposes for which funds were raised under the
Placement, being to:
1.
invest in the growth of core areas of the
Company’s business;
2.
provide working capital for general
operational efficiencies, covering the costs of
the divestment of parts of the Company’s
training business and pursuing recovering of
fees related to the final poor performing
legacy project; and
3. reduce the Company’s net debt position and
minimise, as far as reasonably practicable and
prudent, the Company’s debt draw.
If the securities are being issued under an
agreement, a summary of any other material terms
of the agreement
The Company has agreed to issue the Broker
Options under its agreement with Veritas (Lead
Manager Agreement).
Under the Lead Manager Agreement, Veritas
agreed to provide the Company with brokerage
and management services in connection with the
conduct of the Placement and the Shortfall
Placement. In consideration for Veritas providing
10
Listing Rule 7.3 Requirement
Detail
these services, the Company agreed to issue the
Broker Options to Veritas.
The material terms of the Lead Manager Agreement
is attached as an Appendix to this notice.
If the securities are being issued under, or to fund, a
reverse takeover, information about the reverse
takeover
Not Applicable
Voting exclusion statement
A voting exclusion statement is included for this
resolution below.
For the purposes of Listing Rule 14.1A:
1. If Resolution 2 is passed, the Broker options will be issued to Veritas within no more
than three months from the date of the meeting consistent with Listing Rule 7.3 and
will be excluded in calculating the Company’s Placement Capacity under Listing
Rule 7.1.
2. If Resolution 2 is not passed, the Company may settle the matter for cash
consideration, the value of which has not been determined and would be subject
to negotiation with Veritas.
Voting exclusion statement
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour
of the resolution by or on behalf of:
-
A person who is expected to participate in, or will obtain material benefit as a result
of, the proposed issue (except a benefit solely by reason of being a holder of
ordinary securities in the entity), including Veritas Securities Limited.
-
an associate of that person or persons
However, this does not apply to a vote cast in favour of a resolution by:
-
a person as proxy or attorney for a person who is entitled to vote on the resolution,
in accordance with the directions given to the proxy or attorney to vote on the
resolution in that way; or
-
the chair of the meeting as proxy or attorney for a person who is entitled to vote on
the resolution, in accordance with a direction given to the chair to vote on the
resolution as the chair decides; or
-
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity
on behalf of a beneficiary provided the following conditions are met:
o
the beneficiary provides written confirmation to the holder that the
beneficiary is not excluded from voting, and is not an associate of a person
excluded from voting, on the resolution; and
o
the holder votes on the resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Director’s recommendation
The Directors recommend that Shareholders vote in favour of Resolution 2.
11
Resolution 3: Ratification of previous issue and allotment of Placement Shares
On 27 November 2023, the Company issued 31,823,491 Shares (Placement Shares) under
Listing Rule 7.1 by placement to institutional, sophisticated and strategic investors
(Placement).
Pursuant to the purposes of Listing Rule 7.5, the details of the Placement is as follows:
Details of Placement Shares
Issue Date
27/11/2023
Number of Securities
31,823,491
Class of Securities
Fully paid ordinary shares of the Company
(ASX : VBC)
Issue Price
$0.06 per Share
Terms of Issue
The Shares rank equally with all existing Shares on
issue at the Issue Date
Allottees
Institutional, wholesale and sophisticated investors
identified and otherwise approach by Veritas as
lead manager of the Placement. None of the
Allottees (other than in respect of the Shares
proposed to be issued to the Directors subject to the
approval of Resolution 1) are related parties of the
Company or otherwise persons to whom Listing Rule
10.11 applies, a member of the Key Management
Personnel, a substantial Shareholder of the
Company, an advisor of the Company or an
associate of such persons.
Use of funds raised
1. Invest in the growth of core areas of its business;
2. Provide working capital for general operational
efficiencies, covering costs of the divestments of
parts of the Company’s training business and
pursuing recovery of fees related to the final poor
performing legacy project; and
3. Reduce the Company’s net debt position and
minimise, as far as reasonably practicable and
prudent, the Company’s debt draw.
Voting exclusion statement
A voting exclusion statement is included for this
resolution below.
Further information related to the Placement Shares can be found in the Company’s announcements to the
ASX on 20 November 2023, 24 November 2023 and 27 November 2023.
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount
of equity securities that a listed company can issue without the approval of its
shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on
issue at the start of that period (Placement Capacity).
The Placement shares do not fall within any of the exceptions under Listing Rule 7.2, and
thus was issued in accordance with Listing Rule 7.1 without shareholder approval and
effectively reduced the Company’s Placement Capacity for the subsequent 12 months.
Listing Rule 7.4 allows shareholders of a listed company to approve an issue of equity
securities subsequent to the date those equity securities were issued or agreed to be
issued. If shareholders do approve the issue in this way, it is taken as approved pursuant to
12
Listing Rule 7.1 and the Placement Capacity taken up by the relevant issue of equity
securities is effectively restored.
The Company and its Board wish to retain as much flexibility as possible to issue additional
equity securities utilising the Placement Capacity afforded by Listing Rule 7.1.
Accordingly, this Resolution 3 seeks shareholder approval of the Placement Shares issued
under and for the purposes of Listing Rule 7.4.
For the purposes of Listing Rule 14.1A:
1. If Resolution 3 is passed, the Placement Shares issued will be excluded in
calculating the Company’s Placement Capacity, effectively increasing the number
of equity securities the Company can issue over the 12 months subsequent to the
Placement without shareholder approval.
2. If Resolution 3 is not passed, the Placement Shares will contribute to the calculation
of the Company’s available Placement Capacity, effectively decreasing the
number of equity securities it can issue without seeking further shareholder approval
over the 12 months subsequent to the Placement.
Voting exclusion statement
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour
of the resolution by or on behalf of:
-
A person who participated in the issue of Placement Shares
-
An associate of that person or persons
However, this does not apply to a vote cast in favour of a resolution by:
-
a person as proxy or attorney for a person who is entitled to vote on the resolution,
in accordance with the directions given to the proxy or attorney to vote on the
resolution in that way; or
-
the chair of the meeting as proxy or attorney for a person who is entitled to vote on
the resolution, in accordance with a direction given to the chair to vote on the
resolution as the chair decides; or
-
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity
on behalf of a beneficiary provided the following conditions are met:
o
the beneficiary provides written confirmation to the holder that the
beneficiary is not excluded from voting, and is not an associate of a person
excluded from voting, on the resolution; and
o
the holder votes on the resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Director’s recommendation
The Directors recommend that Shareholders vote in favour of Resolution 3.
13
Glossary
In this Explanatory Statement, the following terms have the following meaning:
Definitions
14
TERM
DEFINITION
General Meeting or Meeting
General meeting of Shareholders of the Company or any adjournment of
it, convened by the Notice.
ASIC
Australian Securities & Investments Commission.
Associates
Has the same meaning as in the Listing Rules.
ASX
ASX Limited ACN 008 624 691, trading as the Australian Securities Exchange
Board or Verbrec Board
Board of Directors of the Company.
Chairperson
The Chairperson of the Board.
Closely Related Party
Has the same meaning as in the Corporations Act.
Company or Verbrec
Verbrec
Share your feedback
Discover